{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&date=2016-07-19", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&date=2016-07-19", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&date=2016-07-19&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&date=2016-07-19&_page=0", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&date=2016-07-19", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&date=2016-07-19", "items" : [{"_about" : "http://data.parliament.uk/resources/540129", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union "} ], "answer" : {"_about" : "http://data.parliament.uk/resources/540129/answer", "answerText" : {"_value" : "
The Government recognises the importance of our research base, which is why we have protected the science budget in real terms from its current level of £4.7 bn for the rest of the parliament.<\/p>
The referendum result has no immediate effect on the right of researchers to apply to or participate in EU research programmes. We remain a part of the EU until negotiations are concluded. While the UK remains a member of the EU, current EU arrangements continue unchanged. UK participants, including those researching mental health issues, can continue to apply to programmes in the usual way. The future of UK access to these programmes is one of many issues to be addressed in our EU negotiations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4091", "label" : {"_value" : "Biography information for Mr Robin Walker"} } , "answeringMemberConstituency" : {"_value" : "Worcester"} , "answeringMemberPrinted" : {"_value" : "Mr Robin Walker"} , "dateOfAnswer" : {"_value" : "2016-07-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-27T10:10:58.793Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "203"} , "answeringDeptShortName" : {"_value" : "Exiting the European Union "} , "answeringDeptSortName" : {"_value" : "Exiting the European Union "} , "date" : {"_value" : "2016-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Life Sciences"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Exiting the European Union, what assessment he has made of the potential effect of the UK leaving the EU on funding for the UK's life sciences sector.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1516", "label" : {"_value" : "Biography information for Andy Slaughter"} } , "tablingMemberConstituency" : {"_value" : "Hammersmith"} , "tablingMemberPrinted" : [{"_value" : "Andy Slaughter"} ], "uin" : "43303"} , {"_about" : "http://data.parliament.uk/resources/540147", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union "} ], "answer" : {"_about" : "http://data.parliament.uk/resources/540147/answer", "answerText" : {"_value" : "
The Innovative Medicines Initiative is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA to boost biomedical innovation. The UK remains a member of the EU until our withdrawal is completed. UK researchers can still apply for Horizon 2020 projects. Future involvement will need to be agreed in forthcoming negotiations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"} } , "answeringMemberConstituency" : {"_value" : "Haltemprice and Howden"} , "answeringMemberPrinted" : {"_value" : "Mr David Davis"} , "dateOfAnswer" : {"_value" : "2016-07-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-28T12:25:09.187Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "203"} , "answeringDeptShortName" : {"_value" : "Exiting the European Union "} , "answeringDeptSortName" : {"_value" : "Exiting the European Union "} , "date" : {"_value" : "2016-07-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Exiting the European Union, what his policy is on future UK involvement in the Innovative Medicines Initiative.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"} } , "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"} , "tablingMemberPrinted" : [{"_value" : "Diana Johnson"} ], "uin" : "43441"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }